372 related articles for article (PubMed ID: 3160784)
1. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
Rocklin RE; Thistle L; Audera C
J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
[TBL] [Abstract][Full Text] [Related]
2. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
Fischer A; Le Deist F; Durandy A; Griscelli C
J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
[TBL] [Abstract][Full Text] [Related]
3. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes.
Staite ND; Messner RP; Zoschke DC
J Immunol; 1987 Oct; 139(7):2424-30. PubMed ID: 2958549
[TBL] [Abstract][Full Text] [Related]
6. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells.
Rola-Pleszczynski M; Pouliot C; Turcotte S; Pignol B; Braquet P; Bouvrette L
J Immunol; 1988 May; 140(10):3547-52. PubMed ID: 2834440
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human B cell proliferation by prostaglandin E2.
Thompson PA; Jelinek DF; Lipsky PE
J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
[TBL] [Abstract][Full Text] [Related]
8. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
Koster FT; Williams JC; Goodwin JS
J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin.
Niwa Y; Sakane T; Fukuda Y; Miyachi Y; Kanoh T
J Clin Lab Immunol; 1985 May; 17(1):37-44. PubMed ID: 2931529
[TBL] [Abstract][Full Text] [Related]
11. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
Papadogiannakis N; Johnsen SA; Olding LB
Clin Exp Immunol; 1985 Jul; 61(1):125-34. PubMed ID: 2931220
[TBL] [Abstract][Full Text] [Related]
12. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
Fischer A; Durandy A; Griscelli C
J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
[TBL] [Abstract][Full Text] [Related]
13. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Shimizu T; Hayashi O; Imura H
Horm Metab Res; 1984 Dec; 16 Suppl 1():114-8. PubMed ID: 6152434
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
15. Decreased natural killer cell activity in atopic eczema.
Hall TJ; Rycroft R; Brostoff J
Immunology; 1985 Oct; 56(2):337-44. PubMed ID: 3876984
[TBL] [Abstract][Full Text] [Related]
16. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
Brown SL; Van Epps DE
J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
[TBL] [Abstract][Full Text] [Related]
17. Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa.
Barrera S; Lai J; Fiocchi C; Roche JK
J Cell Physiol; 1996 Jan; 166(1):130-7. PubMed ID: 8557762
[TBL] [Abstract][Full Text] [Related]
18. Reduced prostaglandin E2 (PGE2) receptors on atopic T lymphocytes.
Rocklin RE; Thistle L
Cell Immunol; 1986 Apr; 99(1):294-9. PubMed ID: 2875801
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
20. Divergent T gamma cell functions in antigen-induced blastogenesis: facilitory interactions with Tnon gamma cells and participation in monocyte- and prostaglandin-mediated suppression.
Kleinhenz ME; Ellner JJ
J Lab Clin Med; 1983 Nov; 102(5):751-61. PubMed ID: 6226756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
